Cohort Dashboard
GP2’s mission is to further understand the genetic architecture of Parkinson’s disease (PD) through genotyping diverse participant groups and studying highly suspected monogenic forms of PD. In support of this mission, we continue to collect diverse cohorts from around the world through collaboration and openly sharing data, processes, and results. Explore the dashboard below to understand our milestones achieved so far, and continue to visit this page as data will be updated monthly.
Total Global Data
Last Updated: January 14, 2023 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova
PROMO-SYSMEDPD
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Ancestry Breakdown for Samples Completed
ShowPROMO-USTP
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Ancestry Breakdown for Samples Completed
ShowProPark
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
PROSPOS
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Ancestry Breakdown for Samples Completed
ShowProtectMove - Institute of Neurogenetics, University of Lübeck
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
ProtectMove - University of Sciences and Technology, Pakistan
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
PUKBB
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
QPP
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Quantitative MRI for Anatomical Phenotyping in Parkinson's Disease
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Quebec Parkinson's Network
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
